Implanet SA
ISIN: FR0013470168 | Ticker: ALIMP | LEI: 969500CIMHFWNM4J4V14
Country: France
IMPLANET is an international company founded by European institutional and private investors, with headquarters near Bordeaux (FR) and a US subsidiary in Boston.
Implanet's focus is on products for the spine, knee and arthroscopy.
Implanet's flagship product, the latest generation Jazz™ implant, is designed to improve the treatment of spinal conditions requiring surgical spinal fusion. Jazz™ is protected by four groups of international patents and has 510(k) clearance from the U.S. Food and Drug Administration (FDA) as well as a CE mark.
2006
Served areaWorldwide
Headcount39
HeadquartersTechnopole Bordeaux Montesquieu Allée François Magendie, 33650 Martillac – France
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 06.02.24 | None | Other | Other | EUR 4,999,999.94 |
| 29.09.23 | None | Other | Sell | EUR 8,707.42 |
| 28.09.23 | None | Other | Sell | EUR 20,552.00 |
| 31.07.23 | None | Other | Sell | EUR 1,875.95 |
FR0013470168
LEI969500CIMHFWNM4J4V14
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.